MARKET

BLCO

BLCO

Bausch + Lomb Corporation
NYSE
15.26
-0.11
-0.72%
Closed 18:29 03/30 EDT
OPEN
15.39
PREV CLOSE
15.37
HIGH
15.51
LOW
15.14
VOLUME
576.76K
TURNOVER
0
52 WEEK HIGH
18.92
52 WEEK LOW
10.45
MARKET CAP
5.41B
P/E (TTM)
-14.9975
1D
5D
1M
3M
1Y
5Y
1D
Should Positive ELIOS Glaucoma Trial Results Require Action From Bausch + Lomb (BLCO) Investors?
Simply Wall St · 23h ago
Bausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call
TipRanks · 1d ago
Weekly Report: what happened at BLCO last week (0323-0327)?
Weekly Report · 1d ago
Stocks in play: Bausch + Lomb Corporation
Barchart · 1d ago
Assessing Bausch + Lomb (NYSE:BLCO) Valuation After Recent Share Price Weakness
Simply Wall St · 4d ago
A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story
The Motley Fool · 6d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 6d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lifecore Biomedical (LFCR), Pyxis Oncology (PYXS) and Bausch + Lomb Corporation (BLCO)
TipRanks · 03/24 12:40
More
About BLCO
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Webull offers Bausch + Lomb Corp stock information, including NYSE: BLCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLCO stock methods without spending real money on the virtual paper trading platform.